Fellowship Council - Display Listing

Program Director(s):
Sebastian G. de la Fuente
Armando Rosales

Description:

The main purpose of Advanced Gastrointestinal Surgery fellowship at Advent Health Orlando Campus is to provide a structured educational and training experience necessary to achieve expertise in complex surgical procedures and patient care. The fellowship duration is 12 months.

This fellowship focuses strongly on the management of complex gastrointestinal and HPB disease processes.

The fellow will spend time performing minimally invasive and open surgeries. There is a strong component of robotics at our institution. Robotic labs and simulators are available to the fellow.

The fellow is considered a junior faculty and expected to manage the services accordingly. NO general surgery inhouse call is required. The fellow will graduated the program with extensive exposure to complex pathology. The faculty is comprised by surgical oncologists, MIS-fellowship trained surgeons, GI surgeons, transplant surgeons, radiologist, etc.

The academic components of the fellowship include weekly morbidity and mortality conferences, tumor board, radiology conferences, attending rounds, journal clubs, etc.

Research is an integral component of the fellowship with both basic science and clinical opportunities available. Full research support including nurses, biostatisticians, etc is available.

Fellows share the services with junior residents and occasionally with medical students. There is ABSOLUTELY no competition for cases with senior residents as our General Surgery Program is fully accreditated through ACGME.

Basic Program Information:

Location: Orlando, Florida
Primary Program Site: AdventHealth Orlando Campus
Primary Hospital: Total bed size, # OR's, # Surgical ICU beds: 2,247-bed acute-care medical facility, serves as a community hospital for Greater Orlando and as a major tertiary referral hospital for Central Florida and much of the Southeast, the Caribbean and Latin America. AdventHealth Orlando is a system of 10 hosp
Secondary Program Site: AdventHealth East Campus
Secondary Hospital: Total bed size, # OR's, # Surgical ICU beds: 295-bed, 5 main OR's
Clinic locations and schedule: 2415 N Orange Ave. Suite 400, Orlando, Fl 32804

Full day Thursdays
University Affiliation:
School of Medicine Affiliation: Loma Linda University
Year Program and/or Designation Established: 2012
Number of Faculty: 6
% of Program Clinical: 95
% of Program Research: 5

Additional Program Information:

Interaction with Residents: Some cases shared
Is there a General Surgery Residency at the Primary Institution? Yes
Is there a General Surgery Residency at the Secondary Institution? Yes
Is there a curriculum in place for fellowship? Yes
Is there a skills lab at the institution with fellow access? Yes
Are there teaching conferences available for the fellow? Yes
Is there an evaluation tool for fellow by faculty in place? Yes
Is there an evaluation tool for faculty by fellow in place? Yes
Papers Accepted For Publication where PD was an author: 40
Publications that Involved Input from the Fellow: 3
Are funds available for the Fellow to attend conferences? Yes

Malpractice Insurance Information:

The fellow(s) only works as a fellow, i.e. does not/will not have attending privileges and the program provides the following:
Claims-based malpractice coverage including a tail for the statute of limitations

Contact Information For Questions:

Maria Cepero
Phone: 407-303-7203
Fax: 407-303-2469
Email: maria.cepero@adventhealth.com
Web: https://www.adventhealth.com/adventhealth-graduate-medical-education/complex-gastrointestinal-surgical-fellowship

Facilities

Dry Lab
Wet lab
Library
Administrative Support
Basic Science Research
Clinical Research
Simulation Lab

Citizenship and Visa Requirements:

Medical School Requirements:

We ONLY accept graduates of U.S. or Canadian Medical Schools

Examinations and Certifications:

Applicants must have passed the USMLE/COMLEX Step 1, 2, & 3 exams

Applicants must have passed the USMLE/COMLEX Step 1 & 2 exams or the Medical Council of Canada Evaluation Exam (MCCEE)

Applicants must have had at least 2 years of prior training in an ACGME accredited residency or fellowship (or Canadian equivalent)

Applicants who hold a General Surgery specialty certificate from a Board or College outside of U.S. or Canada at the beginning of the fellowship

Applicants must be AOBS (American Osteopathic Board of Surgery) eligible or certified

Licensure Requirements and Information:

Candidates must have completed a general surgery residency in the United States, hold an M.D. or equivalent degree and be board eligible or board certified in general surgery. Interested candidates should send their CV and two letters of recommendation to Sebastian G. de la Fuente, MD, program director.

Requirements: Completion of US General Surgery Residency Program, M.D. or equivalent degree, Board eligible or board certified in surgery, 2 letters of recommendations

Accreditation Status	Accreditation Period	Length of Accreditation
Accredited for Complex Gastrointestinal Surgery	2025-2027	2

Fellowship Opportunity # 1

Number of Positions Available: 1
Type of Fellowship: Advanced GI
Duration: 1 year
Start Day: August 1
End Day: July 30
Is this a salaried position? Yes
It is a requirement that the salary must be commensurate to a PGY 6 or greater in the same city. Does your program meet this requirement? Yes
Is the salary guaranteed for the year? Yes
Is there funding available beyond salary for meeting attendance, research, etc? Yes
Is the salary dependent on call? No
Is the Fellow on call? Yes
What are the on call requirements?
What are the estimated fellow weekly work hours?
It is a requirement that Health Insurance be provided. Do you provide health insurance to your fellows? Yes
Teaching Responsibilities: Yes
Courses/Academic Presentations: Yes
Does reimbursement for the above make up part of the salary? No
Does the fellowship contract include a non-compete clause? No

Clinical Outpatient Experience

Fellows participate in the preoperative and postoperative management of the patients. The fellow is required to spend at least 1 day a week with one of the attendings in clinic evaluating patients before surgery and after surgery.

Research/Scholarship Resources

With our ultimate goal being the training of the next generation of leaders in Advanced GI surgery, we provide our fellow with the resources necessary to:

1. Critically evaluate the scientific literature
2. Design and execute experimental studies under the supervision of a mentor
3. Present at local, regional, national, or international scientific meetings
4. Write research manuscripts for publication

In order to achieve these goals, we meet on a regular basis to discuss new projects and ideas and to assess the status of the ongoing research.

Our program counts with the support of biostatisticians, research nurse and coordinator, access to local, regional and national databases, etc. Funding for presentations and travel to national meetings is available.

Program Director(s) Detailed Information

Dr. Sebastian G. de la Fuente MD

At Institution Since: 2012
Program Director Since : 2013
Board Certification: Board Certified

Society Memberships

SAGES

ACS

SSAT

AHPBA

Other

SSO

Areas of Expertise

HPB, GI Oncology

Teaching Qualifications

Summary of Qualifications

Education

General Surgery Residency, Department of Surgery, Duke University Medical Center, Durham, NC, USA

Research Fellowship in GI Surgery, Department of Surgery, Duke University Medical Center, Durham, NC, USA

Surgical Oncology Fellow, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Positions

Assistant Professor of Surgery, University of Central Florida, Orlando, FL, USA

Clinical Assistant Professor of Surgery, Florida State University, Orlando, FL, USA

HPB Surgeon, Division of Surgical Oncology, Florida Hospital Orlando, Orlando, FL, USA

Publications

1: de la Fuente SG, Arnoletti JP. Beyond cytology: why and when does the oncologist require core tissue? Gastrointest Endosc Clin N Am. 2014 Jan;24(1):9-17. doi: 10.1016/j.giec.2013.08.001. Epub 2013 Sep 21. PubMed PMID:24215757.

2: Zenoni SA, Arnoletti JP, de la Fuente SG. Recent Developments in Surgery: Minimally Invasive Approaches for Patients Requiring Pancreaticoduodenectomy. JAMA Surg. 2013 Oct 23. doi: 10.1001/jamasurg.2013.366. [Epub ahead of print] PubMed PMID: 24154790.

3: de la Fuente SG, Deneve JL, Parsons CM, Zager JS, Conley AP, Gonzalez RJ. A comparison between patients with gastrointestinal stromal tumours diagnosed with isolated liver metastases and liver metastases plus sarcomatosis. HPB (Oxford). 2013 Sep;15(9):655-60. doi: 10.1111/hpb.12011. Epub 2012 Dec 27. PubMed PMID: 23458233.

4: de la Fuente SG, Weber J, Hoffe SE, Shridhar R, Karl R, Meredith KL. Initial experience from a large referral center with robotic-assisted Ivor Lewis esophagogastrectomy for oncologic purposes. Surg Endosc. 2013 Sep;27(9):3339-47. doi: 10.1007/s00464-013-2915-6. Epub 2013 Apr 3. PubMed PMID: 23549761.

5: de la Fuente SG. Laparoscopic pancreaticoduodenectomies: a word of caution. J Am Coll Surg. 2013 Jun;216(6):1218. doi: 10.1016/j.jamcollsurg.2013.02.016. PubMed PMID: 23683779.

6: de la Fuente SG, Bennett KM, Scarborough JE. Functional status determines postoperative outcomes in elderly patients undergoing hepatic resections. J Surg Oncol. 2013 Jun;107(8):865-70. doi: 10.1002/jso.23335. Epub 2013 Apr 12. PubMed PMID: 23585324.

7: Reilly C, Zenoni S, Hasan MK, Varadarajulu S, Tran TA, de la Fuente SG, Arnoletti JP. Primary pancreatic Ewing's sarcoma with portal vein tumor thrombosis. J Gastrointest Surg. 2013 May;17(5):1015-9. doi: 10.1007/s11605-012-2098-9. Epub 2012 Nov 29. Review. PubMed PMID: 23192427.

8: Castleberry AW, White RR, De La Fuente SG, Clary BM, Blazer DG 3rd, McCann RL, Pappas TN, Tyler DS, Scarborough JE. The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database. Ann Surg Oncol. 2012 Dec;19(13):4068-77. doi: 10.1245/s10434-012-2585-y. Epub 2012 Aug 30. PubMed PMID: 22932857.

9: de la Fuente SG, Ludwig KA, Tyler DS, Mantyh CR. Ex vivo evaluation of preoperatively treated rectal cancer specimens of patients undergoing radical resection. Ann Surg Oncol. 2012 Jun;19(6):1954-8. doi: 10.1245/s10434-012-2259-9. Epub 2012 Feb 14. PubMed PMID: 22350598.

10: de la Fuente SG, Bennett KM, Pappas TN, Scarborough JE. Pre- and intraoperative variables affecting early outcomes in elderly patients undergoing pancreaticoduodenectomy. HPB (Oxford). 2011 Dec;13(12):887-92. doi: 10.1111/j.1477-2574.2011.00390.x. Epub 2011 Oct 12. PubMed PMID: 22081925; PubMed Central PMCID: PMC3244629.

11: Bhattacharya SD, Williams JB, de la Fuente SG, Kuo PC, Seigler HF. Does protected research time during general surgery training contribute to graduates' career choice? Am Surg. 2011 Jul;77(7):907-10. PubMed PMID: 21944357; PubMed Central PMCID: PMC3720679.

12: de la Fuente SG, Ceppa EP, Reddy SK, Clary BM, Tyler DS, Pappas TN. Incidence of benign disease in patients that underwent resection for presumed pancreatic cancer diagnosed by endoscopic ultrasonography (EUS) and fine-needle aspiration (FNA). J Gastrointest Surg. 2010 Jul;14(7):1139-42. doi: 10.1007/s11605-010-1196-9. Epub 2010 Apr 28. PubMed PMID: 20424928.

13: Ceppa EP, De la Fuente SG, Reddy SK, Stinnett SS, Clary BM, Tyler DS, Pappas TN, White RR. Defining criteria for selective operative management of pancreatic cystic lesions: does size really matter? J Gastrointest Surg. 2010 Feb;14(2):236-44. doi: 10.1007/s11605-009-1078-1. PubMed PMID: 19911240.

14: Reddy SK, Kattan MW, Yu C, Ceppa EP, de la Fuente SG, Fong Y, Clary BM, White RR. Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases. HPB (Oxford). 2009 Nov;11(7):592-9. doi: 10.1111/j.1477-2574.2009.00106.x. PubMed PMID: 20495712; PubMed Central PMCID: PMC2785955.

15: de la Fuente SG, Safford SD, Cantu E, Ludwig KA. Spinal abscess presenting as the initial symptom of Crohn's disease. Int J Colorectal Dis. 2009 May;24(5):601-2. doi: 10.1007/s00384-008-0599-5. Epub 2008 Oct 18. PubMed PMID: 18931849.

16: de la Fuente SG, Smith TP, Rice HE. Functional and anatomic correlation of splenic regeneration following embolization. Pediatr Int. 2009 Apr;51(2):302-5. doi: 10.1111/j.1442-200X.2009.02807.x. PubMed PMID: 19379265.

17: Roller JE, de la Fuente SG, DeMaria EJ, Pryor AD. Laparoscopic Heller myotomy using hook electrocautery: a safe, simple, and inexpensive alternative. Surg Endosc. 2009 Mar;23(3):602-5. doi: 10.1007/s00464-008-9994-9. Epub 2008 Jul 12. PubMed PMID: 18622538.

18: de la Fuente SG, Manson RJ, Ludwig KA, Mantyh CR. Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens. J Gastrointest Surg. 2009 Feb;13(2):269-74. doi: 10.1007/s11605-008-0717-2. Epub 2008 Oct 11. PubMed PMID: 18850250.

19: Ueno T, de la Fuente SG, Abdel-Wahab OI, Takahashi T, Gottfried M, Harris MB, Tatewaki M, Uemura K, Lawson DC, Mantyh CR, Pappas TN. Functional evaluation of the grafted wall with porcine-derived small intestinal submucosa (SIS) to a stomach defect in rats. Surgery. 2007 Sep;142(3):376-83. PubMed PMID: 17723890.

20: de la Fuente SG, Mantyh CR. Reconstruction techniques after proctectomy: what's the best? Clin Colon Rectal Surg. 2007 Aug;20(3):221-30. doi: 10.1055/s-2007-984866. PubMed PMID: 20011203; PubMed Central PMCID: PMC2789510.

21: de la Fuente SG, Demaria EJ, Reynolds JD, Portenier DD, Pryor AD. New developments in surgery: Natural Orifice Transluminal Endoscopic Surgery (NOTES). Arch Surg. 2007 Mar;142(3):295-7. Review. PubMed PMID: 17372056.

22: de la Fuente SG. Enrique Finochietto: the legacy of surgery in Argentina. J Surg Educ. 2007 Mar-Apr;64(2):120-3. PubMed PMID: 17462215.

23: McClaine RJ, Uemura K, McClaine DJ, Shimazutsu K, de la Fuente SG, Manson RJ, White WD, Eubanks WS, Benni PB, Reynolds JD. A description of the preterm fetal sheep systemic and central responses to maternal general anesthesia. Anesth Analg. 2007 Feb;104(2):397-406. PubMed PMID: 17242098.

24: de la Fuente SG, Rice HE. Ingestion of unusual foreign bodies and malrotation: a "perfect storm". Pediatr Surg Int. 2006 Oct;22(10):869-72. Epub 2006 Sep 1. PubMed PMID: 16947024.

25: Fujino K, de la Fuente SG, Takami Y, Takahashi T, Mantyh CR. Attenuation of acid induced oesophagitis in VR-1 deficient mice. Gut. 2006 Jan;55(1):34-40. Epub 2005 Aug 9. PubMed PMID: 16091555; PubMed Central PMCID: PMC1856385.

26: de la Fuente SG, Khuri SF, Schifftner T, Henderson WG, Mantyh CR, Pappas TN. Comparative analysis of vagotomy and drainage versus vagotomy and resection procedures for bleeding peptic ulcer disease: results of 907 patients from the Department of Veterans Affairs National Surgical Quality Improvement Program database. J Am Coll Surg. 2006 Jan;202(1):78-86. Epub 2005 Nov 10. PubMed PMID: 16377500.

27: McClaine RJ, Uemura K, de la Fuente SG, Manson RJ, Booth JV, White WD, Campbell KA, McClaine DJ, Benni PB, Eubanks WS, Reynolds JD. General anesthesia improves fetal cerebral oxygenation without evidence of subsequent neuronal injury. J Cereb Blood Flow Metab. 2005 Aug;25(8):1060-9. PubMed PMID: 15758947.

28: Uemura K, McClaine RJ, de la Fuente SG, Manson RJ, Campbell KA, McClaine DJ, White WD, Stamler JS, Eubanks WS, Reynolds JD. Maternal insufflation during the second trimester equivalent produces hypercapnia, acidosis, and prolonged hypoxia in fetal sheep. Anesthesiology. 2004 Dec;101(6):1332-8. PubMed PMID: 15564940.

29: Fujino K, Takami Y, de la Fuente SG, Ludwig KA, Mantyh CR. Inhibition of the vanilloid receptor subtype-1 attenuates TNBS-colitis. J Gastrointest Surg. 2004 Nov;8(7):842-7; discussion 847-8. PubMed PMID: 15531237.

30: Clary EM, O'Halloran EK, de la Fuente SG, Eubanks S. Videoendoscopic endotracheal intubation of the rat. Lab Anim. 2004 Apr;38(2):158-61. PubMed PMID: 15070455.

31: de la Fuente SG. Early versus delayed management for acute calculous cholecystitis: when should cholecystectomy be performed? Am J Gastroenterol. 2004 Jan;99(1):156-7. PubMed PMID: 14687157.

32: Ueno T, Pickett LC, de la Fuente SG, Lawson DC, Pappas TN. Clinical application of porcine small intestinal submucosa in the management of infected or potentially contaminated abdominal defects. J Gastrointest Surg. 2004 Jan;8(1):109-12. PubMed PMID: 14746842.

33: de la Fuente SG, McMahon RL, Pickett LC, Pappas TN. Sporadic gastric carcinoid tumor laparoscopically resected: a case report. JSLS. 2004 Jan-Mar;8(1):85-7. PubMed PMID: 14974672; PubMed Central PMCID: PMC3015503.

34: de la Fuente SG, Levin LS, Reynolds JD, Olivares C, Pappas TN, Ludwig KA, Mantyh CR. Elective stoma construction improves outcomes in medically intractable pressure ulcers. Dis Colon Rectum. 2003 Nov;46(11):1525-30. PubMed PMID: 14605574.

35: de la Fuente SG, Pinheiro J, Gupta M, Eubanks WS, Reynolds JD. Early postnatal behavior deficits after maternal carbon dioxide pneumoperitoneum during pregnancy. Surg Endosc. 2003 Nov;17(11):1823-5. Epub 2003 Jun 17. PubMed PMID: 12802645.

36: Kihara N, de la Fuente SG, Fujino K, Takahashi T, Pappas TN, Mantyh CR. Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats. Gut. 2003 May;52(5):713-9. PubMed PMID: 12692058; PubMed Central PMCID: PMC1773638.

37: de la Fuente SG, Ludwig KA, Mantyh CR. Preoperative immune status determines anal condyloma recurrence after surgical excision. Dis Colon Rectum. 2003 Mar;46(3):367-73. PubMed PMID: 12626913.

38: de la Fuente SG, Gottfried MR, Lawson DC, Harris MB, Mantyh CR, Pappas TN. Evaluation of porcine-derived small intestine submucosa as a biodegradable graft for gastrointestinal healing. J Gastrointest Surg. 2003 Jan;7(1):96-101. PubMed PMID: 12559190.

39: de la Fuente SG, McMahon RL, Clary EM, Harris MB, Lawson DC, Reynolds JD, Eubanks WS, Pappas TN. Celecoxib (celebrex) increases canine lower esophageal sphincter pressure. J Surg Res. 2002 Sep;107(1):154-8. PubMed PMID: 12384079.

40: De la Fuente SG, Pappas TN. Roscoe Reid Graham (1890 to 1948): the man of the patch. Curr Surg. 2002 Jul-Aug;59(4):428-9. PubMed PMID: 16093183.

Dr. Armando Rosales MD

At Institution Since: 2019
Program Director Since : 2025
Board Certification: Board Certified

Society Memberships

SAGES

ACS

AHPBA

Areas of Expertise

Specializing in foregut, HPB, Minimally invasive techniques and robotics.

Teaching Qualifications

School Merit for Medical Professional Exam (CENEVAL) 5/07Granted to the highest scores in MexicoStep 1 Kaplan Medical Honor Society 2008Step 2 CK Kaplan Medical Honor Society 2009Certificate of Appreciation by UCSD Clinical Physiology Lab 2010

Summary of Qualifications

Education and TrainingUniversidad Autonoma de Baja California Graduate, Tijuana, Mexico 8/00 – 7/05

Medical School State of Sonora General Hospital, Hermosillo, Mexico 8/05 – 7/06

InternshipUniversity Medical Facility, Tijuana, Mexico 8/06 – 7/07

Community Medical ServiceArmando Rosales, MD

Foregut, Hepatobiliary and Pancreatic SurgeryDepartment of Surgical OncologyCancer Institute, AdventHealth OrlandoUniversity of California, San Diego 1/09 – 5/10

Research Associate, Clinical Physiology Laboratory

Mayo Clinic 7/10 – 6/11General Surgery Preliminary PositionMayo Clinic 7/11 – 6/12

Minimally Invasive Surgery Research Fellowship, Department of SurgeryMayo Clinic 7/12 – 6/14

Collaborative Research, Department of SurgeryCleveland Clinic Florida 7/12 – 6/13

General Surgery Resident PreliminaryCleveland Clinic Florida 7/13 – 6/18

General Surgery Resident CategoricalMayo Clinic Florida 8/18 – 7/19

Advance Minimally Invasive Surgery Fellowship (Foregut/HPB surgery

Division of Time

Percentage of Time Spent in Clinical Activity: 95%
Percentage of Time Spent in Research Activity:5%

Case Load as Reported By Fellow(s)

1 Fellow(s) performed 203 cases with 270 procedures during the 2024-2025 Fellowship Year.

2 Fellow(s) performed 287 cases with 320 procedures during the 2023-2024 Fellowship Year.

List of Contributing Faculty

Sebastian G. de la Fuente MD	65%
Area of Expertise HPB and GI Oncology
Role in Training Fellowship Director

Lawrence T Chin MD	5%
Area of Expertise Transplant Surgeon
Role in Training Contributing faculty

Nicholas Feranec MD	5%
Area of Expertise Radiologist
Role in Training Contributing faculty

Armando Rosales MD	5%
Area of Expertise Advanced GI Surgery
Role in Training Asociate PD

Ryan W. Day MD	5%
Area of Expertise Transplant/Surgical Oncology
Role in Training Contributing faculty

Scott Bloom MD	5%
Area of Expertise Robotic surgery
Role in Training Contributing faculty

Peter Peng MD	5%
Area of Expertise Surgical oncology
Role in Training Contributing faculty

Timothy McElveen MD	5%
Area of Expertise General Surgery
Role in Training Contributing faculty

Bernadette Profeta MD	5%
Area of Expertise General surgery/MIS
Role in Training Contributing faculty

Accreditation History

Director	Program	Length	Start	End
Sebastian G. Fuente	Complex Gastrointestinal Surgery	2	2025	2027